Project Grant 2035793
Award Date 1/15/21
Completion Date 12/31/21
Dollars Obligated $256K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Gurnee, IL 60031, USA
Similar Awards
- The National Science Foundation Division of Industrial Innovation awarded MBF Therapeutics Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from January 1, 2022 to December 31, 2022. The grant funds the development of a protective T cell vaccine for SARS CoV-2 (COVID-19). The Engineering program supports innovation, creativity and excellence in engineering research and education to improve quality of life and economic strength. This award furthers those...
- This Project Grant from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provided $255,943 to Athem LLC from February 15, 2021 through March 31, 2022. The grant funded the development of a medical device to isolate and purify therapeutic antibodies from recovered COVID-19 donors. The NSF Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award aimed to advance those goals by...
- The National Science Foundation awarded a $255,981 Small Business Innovation Research Phase I Project Grant to Frezent Biological Solutions Inc. of Valhalla, NY under the Engineering (CFDA 47.041) federal grant program. The grant funds the development of a novel peptide inhibitor of the coronavirus papain-like protease as a prophylactic and antiviral therapeutic for COVID-19, to be administered via inhalation. The Engineering program seeks to improve quality of life and economic strength...
- The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to White Rock Therapeutics under the Engineering federal grant program (CFDA 47.041). The grant will support development of an ACE2 decoy as a pan-coronavirus therapeutic from January 2022 to December 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award will fund initial research...
- Florica Therapeutics, Inc. was awarded a $275,678 Project Grant from the National Science Foundation Division of Industrial Innovation under the Engineering (47.041) federal grant program. The grant will support research from January 15, 2021 through December 31, 2021 to develop hypothalamus stem cell exosomes for the treatment of COVID-19. As part of its mission to improve lives and economic strength through engineering innovation, the NSF Engineering program aims to foster excellence in...
- Eradivir Inc. received a $256,000 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation to develop a therapeutic molecule for COVID-19. Under the grant, awarded February 15, 2021 for the period through January 31, 2022, Eradivir will conduct research at its facilities in West Lafayette, Indiana under the NSF's Engineering program (CFDA #47.041). The Engineering program seeks to improve quality of life and economic strength through fostering...
- The National Science Foundation awarded Fibrosix Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) for the period of March 1, 2021 through August 31, 2021. The grant funding supports Fibrosix's "SBIR PHASE I: QUIETING SYSTEMIC HYPER-INFLAMMATION (COVID-19)" project. Specifically, the grant will enable Fibrosix to conduct research towards developing technologies or techniques to reduce excessive inflammation in response to COVID-19 and future...
- The National Science Foundation Division of Industrial Innovation awarded a $255,908 Project Grant to Verisim Life, Inc. under the Engineering (47.041) federal grant program. The grant supports Verisim Life's efforts to rapidly repurpose and translate COVID-19 therapeutics using an AI-based biosimulation platform. Specifically, the company will apply its platform to research multi-target therapies involving angiotensin-converting enzyme 2 and calcium pathways, which could help combat the...
- Neyroblastgx LLC was awarded a $255,997 Project Grant from the National Science Foundation under the NSF Technology, Innovation, and Partnerships program. The grant will support the company's research efforts to genetically engineer dendritic cells to activate T cells specific to the SARS-CoV-2 spike protein, with the goal of developing a novel approach to treating COVID-19. The research is expected to be conducted between April 2021 and December 2022. The NSF Technology, Innovation, and...
- Spirrow Therapeutics LLC received a $256,000 Small Business Technology Transfer (STTR) Phase I Project Grant from the National Science Foundation under the Engineering program (CFDA 47.041) to develop polymer surfactant therapy for acute respiratory distress syndrome (ARDS), including that caused by COVID-19. The grant period runs from February 15, 2021 through January 31, 2022. The NSF Engineering program seeks to improve quality of life and economic strength through engineering research and...